99mTc-fanolesomab Palatin Technologies

IDrugs. 2003 Nov;6(11):1079-85.

Abstract

99mTc-fanolesomab is a radiolabeled imaging agent which is being developed by Palatin Technologies for use in the diagnosis of various infections, including appendicitis and osteomyelitis.

Publication types

  • Review

MeSH terms

  • Animals
  • Antibodies, Monoclonal* / adverse effects
  • Antibodies, Monoclonal* / pharmacokinetics
  • Clinical Trials as Topic
  • Humans
  • Infections / diagnosis
  • Injections, Intravenous
  • Lewis X Antigen / metabolism
  • Radiopharmaceuticals* / adverse effects
  • Radiopharmaceuticals* / pharmacokinetics
  • Structure-Activity Relationship
  • Technetium*

Substances

  • Antibodies, Monoclonal
  • Lewis X Antigen
  • Radiopharmaceuticals
  • Technetium
  • techneticum TC-99M fanolesomab